KCNQ3 Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNQ3 — Potassium Voltage-Gated Channel Subfamily Q Member 3</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>KCNQ3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Potassium Voltage-Gated Channel Subfamily Q Member 3</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>8q24.22</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/3786" target="_blank">3786</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184160" target="_blank">ENSG00000184160</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://omim.org/entry/121201" target="_blank">121201</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/O43525" target="_blank">O43525</a></td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>Benign Familial Neonatal Seizures, Epilepsy, Early Infantile Epileptic Encephalopathy</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Brain, Substantia Nigra, [Cortex](/brain-regions/cortex), [Hippocampus](/brain-regions/hippocampus)</td>
</tr>
<tr>
<th class="infobox-subheader" colspan="2">Key Mutations</th>
</tr>
<tr>
<td colspan="2" style="font-size:0.85em">G310V, R230G, D305G, W344R</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">20 edges</a></td>
</tr>
</table>
KCNQ3 — Potassium Voltage-Gated Channel Subfamily Q Member 3
Overview
Mermaid diagram (expand to render)
KCNQ3 (Potassium Voltage-Gated Channel Subfamily Q Member 3, also known as Kv7.3) is a gene located on chromosome 8q24.22 that encodes a voltage-gated potassium channel protein essential for neuronal excitability regulation. The KCNQ3 protein forms heteromeric M-channels (M-currents) with [KCNQ2](/proteins/kcnq2-protein) subunits, which are critical for controlling neuronal resting membrane potential and preventing hyperexcitability [@jentsch2000]. Mutations in KCNQ3 are primarily associated with Benign Familial Neonatal Seizures (BFNS) and various forms of epilepsy, but emerging research suggests potential roles in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease) [@plant2016].
The gene is catalogued as NCBI Gene ID [3786](https://www.ncbi.nlm.nih.gov/gene/3786), Ensembl ID ENSG00000184160, OMIM [121201](https://omim.org/entry/121201), and UniProt [O43525](https://www.uniprot.org/uniprot/O43525).
Function
M-Channel Biology
The KCNQ3 protein is a core component of the voltage-gated potassium channel subfamily Q, specifically the M-channel (Kv7.2/Kv7.3 channel). M-channels are slowly activating and deactivating potassium channels that regulate neuronal excitability by controlling the resting membrane potential [@jentsch2000]. When KCNQ2/3 channels open, they allow potassium efflux, which hyperpolarizes the neuron and makes it less likely to fire action potentials. This function is crucial for:
- Neuronal resting membrane potential maintenance: KCNQ2/3 channels contribute to the M-current, which sets the resting membrane potential around -70 mV in [neurons](/entities/neurons)
- Action potential threshold regulation: By controlling M-current properties, these channels influence how easily neurons can fire action potentials
- Repetitive firing regulation: M-channels limit high-frequency action potential generation, preventing neuronal hyperexcitability
Brain Expression
KCNQ3 is widely expressed throughout the central nervous system with high expression in:
- Cortex: Both layer 5 pyramidal neurons and interneurons express KCNQ3, contributing to cortical circuit excitability
- Hippocampus: CA1 and CA3 pyramidal neurons show strong KCNQ3 expression, particularly in dendrites where they regulate synaptic integration
- Substantia Nigra: Dopaminergic neurons in the substantia pars compacta express KCNQ3, which may influence their vulnerability in [Parkinson's disease](/diseases/parkinsons-disease)
- Thalamus: Thalamic relay neurons express KCNQ3, contributing to thalamocortical rhythm regulation
- Brainstem: Respiratory and cardiovascular control centers express KCNQ3
Expression data is available from the [Allen Human Brain Atlas](https://human.brain-map.org/microarray/search/show?search_term=KCNQ3).
Protein Structure
The KCNQ3 protein contains six transmembrane domains (S1-S6), with the S4 segment serving as the voltage sensor. The pore region is formed between S5 and S6 segments, and the channel assembles as a tetramer. The N-terminus and C-terminus contain domains important for channel trafficking, assembly, and modulation.
Disease Associations
Benign Familial Neonatal Seizures (BFNS)
KCNQ3 mutations account for approximately 10-15% of BFNS cases, a genetic epilepsy syndrome characterized by seizures that begin in the first week of life and typically resolve by 4-24 months [@schroeder1998]. Most BFNS-causing mutations result in loss-of-function of the M-channel, reducing the M-current by 25-50%. Key BFNS-associated mutations include:
- G310V: Located in the S4-S5 linker, this mutation reduces channel open probability
- R230G: Disrupts voltage sensor function
- D305G: Affects channel gating
Early Infantile Epileptic Encephalopathy (EIEE)
More severe de novo KCNQ3 mutations can cause EIEE, formerly known as Ohtahara syndrome, characterized by severe early-onset seizures and developmental regression [@weckhuysen2013]. These mutations often cause more severe channel dysfunction than BFNS mutations.
Alzheimer's Disease
Emerging evidence links KCNQ channel dysfunction to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:
- [Amyloid-beta](/proteins/amyloid-beta) effects: Aβ oligomers can enhance M-current activity in hippocampal neurons, paradoxically reducing neuronal excitability and contributing to cognitive deficits [@plant2016]
- [Tau](/proteins/tau) pathology: Hyperphosphorylated [tau](/proteins/tau) may interact with KCNQ3 and alter its subcellular localization
- Neuronal hyperexcitability: While early AD shows reduced excitability, later stages feature network hyperexcitability that may involve KCNQ channel dysregulation
Parkinson's Disease
KCNQ3 may play a protective role in [dopaminergic neurons](/cell-types/dopaminergic-neurons) vulnerable in [Parkinson's disease](/diseases/parkinsons-disease):
- Oxidative stress protection: KCNQ channels may help neurons withstand oxidative stress through membrane potential regulation
- Excitotoxicity prevention: By limiting calcium influx through voltage-gated calcium channels (secondary to M-current regulation), KCNQ3 may protect dopaminergic neurons
- Mitochondrial function: Some studies suggest KCNQ channels interact with mitochondrial proteins
Therapeutic Implications
Potassium Channel Openers
Retigabine (ezogabine), a KCNQ2/3 channel opener, has been investigated for neurological conditions:
- Anti-epileptic effects: Retigabine enhances M-current and reduces neuronal hyperexcitability [@gunthorpe2012]
- Neuroprotective potential: By reducing excitotoxicity, KCNQ openers may protect against neurodegeneration
Drug Development Challenges
- Selectivity: Developing KCNQ3-selective modulators over KCNQ2/5 is challenging
- Side effects: KCNQ channel activation can cause dizziness, tremor, and weight gain
- [Blood-brain barrier](/entities/blood-brain-barrier) penetration: CNS delivery remains a key challenge
Key Mutations
| Mutation | Location | Effect |
|----------|----------|--------|
| G310V | S4-S5 linker | Reduced open probability |
| R230G | S4 voltage sensor | Altered voltage dependence |
| D305G | S5 domain | Gating defect |
| W344R | S6 domain | Dominant-negative effect |
Interactions
Protein Interactions
- KCNQ2: Core subunit for M-channel formation [@jentsch2000]
- KCNQ5: Can form heteromeric channels in some brain regions
- Calmodulin: Regulates KCNQ3 trafficking and function
- PIEZO1: Mechanical sensitivity may modulate KCNQ3 activity
Signaling Pathways
- cAMP/PKA: PKA phosphorylation reduces M-current
- PI3K/Akt: Akt can phosphorylate and enhance KCNQ3 function
- Calcium: Calcium-activated signaling modulates M-channel activity
External Links
- NCBI Gene: [https://www.ncbi.nlm.nih.gov/gene/3786](https://www.ncbi.nlm.nih.gov/gene/3786)
- Ensembl: [https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184160](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184160)
- OMIM: [https://omim.org/entry/121201](https://omim.org/entry/121201)
- UniProt: [https://www.uniprot.org/uniprot/O43525](https://www.uniprot.org/uniprot/O43525)
- Allen Human Brain Atlas: [KCNQ3 expression](https://human.brain-map.org/microarray/search/show?search_term=KCNQ3)
See Also
- [Genes Index](/genes)
- [KCNQ2 Gene](/proteins/kcnq2-protein)
- [KCNQ5 Gene](/proteins/kcnq5-protein)
- [Potassium Channels](/proteins)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Epilepsy](/diseases/epilepsy)
- [Mechanisms Index](/mechanisms)
References
[Unknown, Jentsch, T.J. (2000). Neuronal KCNQ potassium channels: physiology and role in disease. Nature Reviews Neuroscience, 1(1), 21-30 (2000)](https://pubmed.ncbi.nlm.nih.gov/11252739/)
[Plant, L.D. et al., (2016). A common mechanism for amyloid-beta effects on potassium channel function in Alzheimer's disease. Proceedings of the National Academy of Sciences, 113(31), E4405-E4414 (2016)](https://pubmed.ncbi.nlm.nih.gov/27457957/)
Schroeder, B.C. et al., (1998). Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 channels in BFNE. Nature, 396(6712), 687-690 (1998)
Weckhuysen, S. et al., (2013). KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy. Annals of Neurology, 73(1), 5-17 (2013)
[Gunthorpe, M.J. et al., (2012). The evolution of retigabine. Nature Reviews Drug Discovery, 11(2), 141-168 (2012)](https://pubmed.ncbi.nlm.nih.gov/22212679/)Pathway Diagram
The following diagram shows the key molecular relationships involving KCNQ3 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)